Arcus Biosciences, Inc. - Common Stock (RCUS)
CUSIP: 03969F109
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 122,470,452
- Total 13F shares
- 44,391,126
- Share change
- +2,542,465
- Total reported value
- $760,991,949
- Put/Call ratio
- 16%
- Price per share
- $17.14
- Number of holders
- 127
- Value change
- +$17,571,170
- Number of buys
- 73
- Number of sells
- 66
Quarterly Holders Quick Answers
What is CUSIP 03969F109?
CUSIP 03969F109 identifies RCUS - Arcus Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03969F109:
Top shareholders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Alphabet Inc. |
13F
|
Company |
4.1%
|
5,049,786
|
$124,932,000 | — | 30 Jun 2020 | |
| FMR LLC |
13F
|
Company |
2.2%
|
2,705,575
|
$66,936,000 | — | 30 Jun 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.2%
|
2,639,092
|
$65,292,000 | — | 30 Jun 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
2,193,120
|
$54,257,000 | — | 30 Jun 2020 | |
| Boxer Capital, LLC |
13F
|
Company |
1.7%
|
2,084,883
|
$51,580,000 | — | 30 Jun 2020 | |
| BVF INC/IL |
13F
|
Company |
1.5%
|
1,882,722
|
$46,579,000 | — | 30 Jun 2020 | |
| Invus Financial Advisors, LLC |
13F
|
Company |
1.5%
|
1,842,077
|
$45,573,000 | — | 30 Jun 2020 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.5%
|
1,810,000
|
$44,779,000 | — | 30 Jun 2020 | |
| Peter Svennilson |
13F
|
Individual |
1.4%
|
1,767,676
|
$43,732,000 | — | 30 Jun 2020 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.4%
|
1,735,581
|
$42,938,000 | — | 30 Jun 2020 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
1,587,499
|
$39,275,000 | — | 30 Jun 2020 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.82%
|
1,000,000
|
$24,740,000 | — | 30 Jun 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.73%
|
892,604
|
$22,083,000 | — | 30 Jun 2020 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.72%
|
884,870
|
$21,892,000 | — | 30 Jun 2020 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.66%
|
805,074
|
$19,918,000 | — | 30 Jun 2020 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.6%
|
730,000
|
$17,177,000 | — | 30 Jun 2020 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.51%
|
625,000
|
$15,463,000 | — | 30 Jun 2020 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.5%
|
614,845
|
$15,211,000 | — | 30 Jun 2020 | |
| Avidity Partners Management LP |
13F
|
Company |
0.48%
|
589,000
|
$14,572,000 | — | 30 Jun 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.45%
|
552,689
|
$13,673,000 | — | 30 Jun 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.45%
|
550,367
|
$13,616,000 | — | 30 Jun 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.4%
|
487,083
|
$12,050,000 | — | 30 Jun 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.38%
|
469,407
|
$11,613,000 | — | 30 Jun 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.36%
|
445,282
|
$11,016,000 | — | 30 Jun 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.34%
|
411,042
|
$10,169,000 | — | 30 Jun 2020 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.33%
|
401,164
|
$9,925,000 | — | 30 Jun 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.3%
|
370,026
|
$9,155,000 | — | 30 Jun 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.3%
|
367,318
|
$9,087,000 | — | 30 Jun 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.24%
|
291,446
|
$7,211,000 | — | 30 Jun 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.23%
|
281,427
|
$6,962,000 | — | 30 Jun 2020 | |
| Holocene Advisors, LP |
13F
|
Company |
0.23%
|
277,100
|
$6,855,000 | — | 30 Jun 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.21%
|
256,253
|
$6,340,000 | — | 30 Jun 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.21%
|
252,100
|
$6,237,000 | — | 30 Jun 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.2%
|
250,000
|
$6,185,000 | — | 30 Jun 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.19%
|
233,744
|
$5,783,000 | — | 30 Jun 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
0.18%
|
222,923
|
$5,515,000 | — | 30 Jun 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.18%
|
220,350
|
$5,451,000 | — | 30 Jun 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
169,390
|
$4,190,000 | — | 30 Jun 2020 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.14%
|
166,889
|
$4,129,000 | — | 30 Jun 2020 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.13%
|
160,000
|
$3,958,000 | — | 30 Jun 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.13%
|
159,799
|
$3,953,000 | — | 30 Jun 2020 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.12%
|
146,152
|
$3,616,000 | — | 30 Jun 2020 | |
| Copernicus Capital Management, LLC |
13F
|
Company |
0.1%
|
124,404
|
$3,078,000 | — | 30 Jun 2020 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.1%
|
121,534
|
$3,007,000 | — | 30 Jun 2020 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.09%
|
110,000
|
$2,721,000 | — | 30 Jun 2020 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.08%
|
101,125
|
$2,502,000 | — | 30 Jun 2020 | |
| MARTINGALE ASSET MANAGEMENT L P |
13F
|
Company |
0.08%
|
94,393
|
$2,336,000 | — | 30 Jun 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
91,582
|
$2,265,000 | — | 30 Jun 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.07%
|
88,155
|
$2,180,000 | — | 30 Jun 2020 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.07%
|
87,058
|
$2,154,000 | — | 30 Jun 2020 |
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q3 2020
As of 30 Sep 2020,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,391,126 shares.
The largest 10 holders included
Alphabet Inc., BlackRock Inc., BVF INC/IL, PFM Health Sciences, LP, STATE STREET CORP, FMR LLC, VANGUARD GROUP INC, BOXER CAPITAL, LLC, Invus Financial Advisors, LLC, and EcoR1 Capital, LLC.
This page lists
127
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
138
Q3 2020 holders
127
Holder diff
-11
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.